The neurogene BTG2TIS21/PC3 is transactivated by ΔNp73α via p53 specifically in neuroblastoma cells

Journal of Cell Science

Volumn 118, Issue 6, 2005, Pages 1245-1253

  Goldschneider, David ^a   Million, Karine ^a   Meiller, Anne ^c   Haddada, Hedi ^a   Puisieux, Alain ^b   Bénard, Jean ^a   May, Evelyne ^c,d   Douc Rasy, Sétha ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE LÉON BÉRARD   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d INSTITUT ANDRÉ LWOFF   (France)

Author keywords

Apoptosis; BTG2TIS21 PC3; Development; Differentiation; Neuroblastoma; p53; p73; Transactivation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; LUCIFERASE; PROTEIN P53; PROTEIN P73; BTG2 PROTEIN, HUMAN; DNA BINDING PROTEIN; IMMEDIATE EARLY PROTEIN; ISOPROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; RECOMBINANT PROTEIN; TP73 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CANCER; BTG2 GENE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; ENZYME ANALYSIS; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UPREGULATION; WILD TYPE; ADENOVIRUS; APOPTOSIS; CELL CULTURE; CELL DIFFERENTIATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NEUROBLASTOMA; PLASMID; PROTEIN TERTIARY STRUCTURE; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOVIRIDAE; APOPTOSIS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; DNA-BINDING PROTEINS; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; HUMANS; IMMEDIATE-EARLY PROTEINS; LUCIFERASES; NEUROBLASTOMA; NUCLEAR PROTEINS; PLASMIDS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 17244376596     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01704     Document Type: Article

References (38)

1. Agami, R., Blandino, G., Oren, M. and Shaul, Y. (1999). Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature 399, 809-813.
2. Bénard, J., Douc-Rasy, S. and Ahomadegbe, J. C. (2003). TP53 family members and human cancers. Hum. Mutat. 21 182-191.
3. Bradbury, A., Possenti, R., Shooter, E. M. and Tirone, F. (1991). Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc. Natl. Acad. Sci. USA 88, 3353-3357.
4. Casciano, I., Mazzocco, K., Boni, L., Pagnan, G., Banelli, B., Allemanni, G., Ponzoni, M., Tonini, G. P. and Romani, M. (2002). Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ. 9, 246-251.
5. Chi, S. W., Ayed, A. and Arrowsmith, C. H. (1999). Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain. EMBO J. 18, 4438-4445.
6. Davison, T. S., Vagner, C., Kaghad, M., Ayed, A., Caput, D. and Arrowsmith, C. H. (1999). p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53. J. Biol. Chem. 274, 18709-18714.
7. De Laurenzi, V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M. and Melino, G. (1998). Two new p73 splice variants, gamma and Delta, with different transcriptional activity. J. Exp. Med. 188, 1763-1768.
8. Douc-Rasy, S., Barrois, M., Echeynne, M., Kaghad, M., Blanc, E., Raguenez, G., Goldschneider, D., Terrier-Lacombe, M. J., Hartmann, O., Moll, U. et al. (2002). ΔN-p73alpha accumulates in human neuroblastic tumors. Am. J. Pathol. 160, 631-639.
9. Drané, P., Bravard, A., Bouvard, V. and May, E. (2001). Reciprocal downregulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis. Oncogene 20 430-439.
10. Drané, P., Leblanc, V., Miro-Mur, F., Saffroy, R., Debuire, B. and May, E. (2002). Accumulation of an inactive form of p53 protein in cells treated with TNF alpha. Cell Death Differ. 9, 527-537.
11. Duriez, C., Falette, N., Audoynaud, C., Moyret-Lalle, C., Bensaad, K., Courtois, S., Wang, Q., Soussi, T. and Puisieux, A. (2002). The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene. Gene 282, 207-214.
12. El-Deiry, W. (1998). Regulation of p53 downstream genes. Cancer Biology 8, 345-357.
13. el Ghissassi, F., Valsesia-Wittmann, S., Falette, N., Duriez, C., Walden, P. D. and Puisieux, A. (2002). BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells. Oncogene 21, 6772-6778.
14. Ferrandis, E., da Silva, J., Riou, G. and Bénard, J. (1994). Coactivation of the MDR 1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse. Cancer Res. 15, 2256-2261.
15. Fillippovich, I., Sorokina, N., Gatei, M., Haupt, Y., Hobson, K., Moallem, E., Spring, K., Mould, M., McGuckin, M. A., Lavin, M. F. et al. (2001). Transactivation-deficient p73alpha (p7Δexon2) inhibits apoptosis and competes with p53. Oncogene 20, 514-522.
16. Goldschneider, D., Blanc, E., Raguenez, G., Haddada, H., Benard, J. and Douc-Rasy, S. (2003). When p53 needs p73 to be functional - forced p73 expression induces nuclear accumulation of endogenous p53 protein. Cancer Lett. 197, 99-103.
17. Goldschneider, D., Blanc, E., Raguenez, G., Barrois, M., Legrand, A., le Roux, G., Haddada, H., Benard, J. and Douc-Rasy, S. (2004). Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line. J. Cell Sci. 117, 293-301.
18. Gong, J. G., Costanzo, A., Yang, H. Q., Melino, G., Kaelin, W. G., Jr., Levrero, M. and Wang, J. Y. (1999). The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399, 806-809.
19. Iacopetti, P., Barsacchi, G., Tirone, F., Maffei, L. and Cremisi, F. (1994). Developmental expression of PC3 gene is correlated with neuronal cell birthday. Mech. Dev. 47, 127-137.
20. Johnson, R. A., Ince, T. A. and Scotto, K. W. (2001). Transcriptional repression by p53 through direct binding to a novel DNA element. J. Biol. Chem. 276, 27716-27720.
21. Jost, C. A., Marin, M. C. and Kaelin, W. G., Jr. (1997). p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 389, 191-194.
22. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X. et al. (1997). Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90, 809-819.
23. Kartasheva, N. N., Contente, A., Lenz-Stoppler, C., Roth, J. and Dobbelstein, M. (2002). p53 induces the expression of its antagonist p73ΔN, establishing an autoregulatory feedback loop. Oncogene 21, 4715-4727.
24. Liu, G., Nozell, S., Xiao, H. and Chen, X. (2004). DeltaNp73beta is active in transactivation and growth suppression. Mol. Cell. Biol. 24, 487-501.
25. Melamed, J., Kernizan, S. and Walden, P. D. (2002). Expression of B-cell translocation gene 2 protein in normal human tissues. Tissue Cell 34, 28-32.
26. Miro-Mur, F., Meiller, A., Haddada, H. and May, E. (2003). p73alpha expression induces both accumulation and activation of wt-p53 independent of the p73alpha transcriptional activity. Oncogene 22, 5451-5456.
27. Munsch, D., Watanabe-Fukunaga, R., Bourdon, J. C., Nagata, S., May, E., Yonish-Rouach, E., and Reisdorf, P. (2000). Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis. J. Biol. Chem. 275, 3867-3872.
28. Morel, A. P., Sentis, S., Bianchin, C., le Romancer, M., Jonard, L., Rostan, M. C., Rimokh, R. and Corbo, L. (2003). BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms. J. Cell Sci. 116 2929-2936.
29. Nakagawa, T., Takahashi, M., Ozaki, T., Watanabe, K. K., Todo, S., Mizuguchi, H., Hayakawa, T. and Nakagawara, A. (2002). Autoinhibitory regulation of p73 by ΔNp73 to modulate cell survival and death through a p73-specific target element within the DeltaN-p73 promoter. Mol. Cell. Biol. 22, 2575-2585.
30. Ozaki, T., Naka, M., Takada, N., Tada, M., Sakiyama, S. and Nakagawara, A. (1999). Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells. Cancer Res. 59, 5902-5907.
31. Rouault, J. P., Falette, N., Guehenneux, F., Guillot, C., Rimokh, R., Wang, Q., Berthet, C., Moyret-Lalle, C., Savatier, P., Pain, B. et al. (1996). Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat. Genet. 14, 482-486.
32. Stiewe, T., Theseling, C. C. and Putzer, B. M. (2002). Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. J. Biol. Chem. 277, 14177-14185.
33. Takada, N., Ozaki, T., Ichimiya, S., Todo, S. and Nakagawara, A. (1999). Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas. Cancer Res. 59 2810-2814.
34. Tirone, F. (2001). The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J. Cell Physiol 187, 155-165.
35. Vossio, S., Palescandolo, E., Pediconi, N., Moretti, F., Balsano, C., Levrero, M. and Costanzo, A. (2002). ΔN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest. Oncogene 21, 3796-3803.
36. Yang, A., Kaghad, M., Caput, D. and McKeon, F. (2002). On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 18, 90-95.
37. Zaika, A. I., Slade, N., Erster, S. H., Sansome, C., Joseph, T. W., Pearl, M., Chalas, E. and Moll, U. M. (2002). DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is upregulated in human tumors. J. Exp. Med. 196, 765-780.
38. Zeng, X., Chen, L., Jost, C. A., Maya, R., Keller, D., Wang, X., Kaelin, W. G., Jr., Oren, M., Chen, J. and Lu, H. (1999). MDM2 suppresses p73 function without promoting p73 degradation. Mol. Cell. Biol. 19, 3257-3266.